[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO983555L - Ny formulering - Google Patents

Ny formulering

Info

Publication number
NO983555L
NO983555L NO983555A NO983555A NO983555L NO 983555 L NO983555 L NO 983555L NO 983555 A NO983555 A NO 983555A NO 983555 A NO983555 A NO 983555A NO 983555 L NO983555 L NO 983555L
Authority
NO
Norway
Prior art keywords
new
wording
new wording
mug
budesonide
Prior art date
Application number
NO983555A
Other languages
English (en)
Other versions
NO983555D0 (no
Inventor
Hans Nilsson
Gordon Santesson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26662810&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO983555(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from SE9604486A external-priority patent/SE9604486D0/xx
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO983555L publication Critical patent/NO983555L/no
Publication of NO983555D0 publication Critical patent/NO983555D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
NO983555A 1996-12-05 1998-08-03 Ny formulering NO983555D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9604486A SE9604486D0 (sv) 1996-12-05 1996-12-05 Novel formulation
US08/846,960 US6291445B1 (en) 1996-12-05 1997-04-29 Low dose budesonide formulations and uses thereof
PCT/SE1997/001998 WO1998024450A1 (en) 1996-12-05 1997-11-28 Novel formulation

Publications (2)

Publication Number Publication Date
NO983555L true NO983555L (no) 1998-08-03
NO983555D0 NO983555D0 (no) 1998-08-03

Family

ID=26662810

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983555A NO983555D0 (no) 1996-12-05 1998-08-03 Ny formulering

Country Status (23)

Country Link
US (2) US6686346B2 (no)
EP (1) EP0907365B1 (no)
JP (1) JP2000508675A (no)
CN (1) CN1168450C (no)
AT (2) ATE239482T1 (no)
AU (1) AU726515B2 (no)
BE (1) BE1011394A5 (no)
CZ (1) CZ295792B6 (no)
DE (2) DE69738000T2 (no)
DK (1) DK0907365T3 (no)
ES (1) ES2133130B1 (no)
FR (1) FR2756739B1 (no)
GR (1) GR1003011B (no)
HK (1) HK1020522A1 (no)
HU (1) HUP0000575A3 (no)
IE (1) IE970854A1 (no)
IL (1) IL125534A (no)
NL (1) NL1007706C2 (no)
NO (1) NO983555D0 (no)
NZ (1) NZ330925A (no)
PT (1) PT907365E (no)
TR (1) TR199801501T1 (no)
WO (1) WO1998024450A1 (no)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2756739B1 (fr) * 1996-12-05 2000-04-28 Astra Ab Nouvelle formulation de budesonide
MY133181A (en) * 1998-09-10 2007-10-31 Schering Corp Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
WO2003026611A2 (en) 2001-09-26 2003-04-03 Baxter International Inc. Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US7811606B2 (en) 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20050026887A1 (en) * 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a steroid
WO2005027853A2 (en) * 2003-09-19 2005-03-31 University Of Louisville Research Foundation Inc Method for treating snoring and sleep apnea with leukotriene antagonists
US20070020298A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US20070110788A1 (en) * 2005-11-14 2007-05-17 Hissong James B Injectable formulation capable of forming a drug-releasing device
US20070264296A1 (en) * 2006-05-10 2007-11-15 Myntti Matthew F Biofilm extracellular polysachharide solvating system
US7993675B2 (en) 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US7959943B2 (en) * 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
US7976873B2 (en) * 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
ES2298049B1 (es) * 2006-07-21 2009-10-20 Laboratorios Almirall S.A. Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
US8088095B2 (en) 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
ES2493641T3 (es) * 2007-06-28 2014-09-12 Cydex Pharmaceuticals, Inc. Administración nasal de soluciones acuosas de corticosteroides
CA2608561A1 (en) * 2007-10-29 2009-04-29 Carl Paluszkiewicz Motorcycle wind deflector accessory support
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20090131386A1 (en) * 2007-11-13 2009-05-21 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
CA2704957A1 (en) 2007-11-13 2009-05-22 Meritage Pharma, Inc. Compositions for the treatment of gastrointestinal inflammation
US20090123551A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Gastrointestinal delivery systems
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
JP2011524367A (ja) 2008-06-12 2011-09-01 メドトロニック・ゾーメド・インコーポレーテッド 慢性の創傷を治療するための方法
WO2010042427A2 (en) 2008-10-06 2010-04-15 Microbial Defense Systems, Llc Antimicrobial composition and methods of making and using same
CA2765033C (en) * 2009-06-12 2020-07-14 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
EP2706845B1 (en) 2011-05-10 2021-06-23 Next Science IP Holdings Pty Ltd Antimicrobial solid and methods of making and using same
CN112516087B (zh) * 2020-12-24 2023-03-24 四川普锐特药业有限公司 布地奈德鼻喷剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992534A (en) * 1972-05-19 1976-11-16 Ab Bofors Compositions and method of treating with component B of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steriods
SE378109B (no) * 1972-05-19 1975-08-18 Bofors Ab
PL164294B1 (pl) * 1990-12-20 1994-07-29 Inst Farmaceutyczny Sposób otrzymywania diastereoizomeru /22R/-16a , 17a-butylidenodioksy-11 ß 21-dihydroksy-1,4-pregnadien-3,20-dionu PL
DK0613371T3 (da) * 1991-12-18 2002-05-13 Astrazeneca Ab Ny kombination af formoterol og budesonid
GB2269992A (en) * 1992-08-14 1994-03-02 Rh Ne Poulenc Rorer Limited Powder inhalation formulations
US5509404A (en) 1994-07-11 1996-04-23 Aradigm Corporation Intrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values
AU6392496A (en) 1995-06-29 1997-01-30 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
AU6290396A (en) * 1995-06-29 1997-01-30 Mcneil-Ppc, Inc. The combination of topical nasal mast cell stabilizers and topical nasal steroids
EP0780127A1 (en) * 1995-12-19 1997-06-25 The Procter & Gamble Company A nasal spray containing a steroid and a antihistamine
AU3153797A (en) * 1996-06-04 1998-01-05 Procter & Gamble Company, The A nasal spray containing an intranasal steroid and an antihistamine
FR2756739B1 (fr) * 1996-12-05 2000-04-28 Astra Ab Nouvelle formulation de budesonide
SE9604486D0 (sv) * 1996-12-05 1996-12-05 Astra Ab Novel formulation

Also Published As

Publication number Publication date
ATE369118T1 (de) 2007-08-15
DK0907365T3 (da) 2003-08-04
EP0907365B1 (en) 2003-05-07
CZ243798A3 (cs) 1998-11-11
GR970100477A (el) 1998-08-31
US20020016315A1 (en) 2002-02-07
DE69721766D1 (de) 2003-06-12
HUP0000575A2 (hu) 2000-10-28
CN1168450C (zh) 2004-09-29
NO983555D0 (no) 1998-08-03
FR2756739B1 (fr) 2000-04-28
GR1003011B (el) 1998-11-20
NZ330925A (en) 2000-05-26
BE1011394A5 (fr) 1999-08-03
IL125534A0 (en) 1999-04-11
US6686346B2 (en) 2004-02-03
DE69721766T2 (de) 2004-03-04
PT907365E (pt) 2003-09-30
ES2133130B1 (es) 2000-03-01
WO1998024450A1 (en) 1998-06-11
US20040101486A1 (en) 2004-05-27
HUP0000575A3 (en) 2001-03-28
DE69738000D1 (de) 2007-09-20
CZ295792B6 (cs) 2005-11-16
ES2133130A1 (es) 1999-08-16
JP2000508675A (ja) 2000-07-11
CN1210467A (zh) 1999-03-10
TR199801501T1 (xx) 1999-02-22
FR2756739A1 (fr) 1998-06-12
IE970854A1 (en) 1998-10-07
AU726515B2 (en) 2000-11-09
US6986904B2 (en) 2006-01-17
IL125534A (en) 2003-06-24
HK1020522A1 (en) 2000-05-12
DE69738000T2 (de) 2008-04-17
NL1007706A1 (nl) 1998-06-08
NL1007706C2 (nl) 1998-09-22
EP0907365A1 (en) 1999-04-14
AU5421198A (en) 1998-06-29
ATE239482T1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
NO983555L (no) Ny formulering
SE9604486D0 (sv) Novel formulation
GB2365772A (en) Factor
DE69726245D1 (de) Befeuchtungsgerät zur Behandlung von Atemstillstand im Schlaf
PL323825A1 (en) Peptidyloheterocycli compounds useful in treating diorders associated with thrombosin
DE69117117D1 (de) Reinigungszusammensetzung zur Vorbeugung und Milderung von Hautreizungen
MX9603560A (es) Composiciones de prostaglandinas estables en almacenamiento.
TR200000726T2 (tr) Budesonid ve formoterol'ün yeni kullanımı.
HK1105580A1 (en) Use of isoflavone compounds in the manufacture of medicament and composition comprising the same
HK1015269A1 (en) Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof
FI971969A0 (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
SE9603669D0 (sv) New combination
UA41355C2 (uk) Засіб для лікування нейро-сніду
HU229458B1 (en) Pharmaceutical compositions containing zolmitriptan
IL115589A0 (en) Use of cck-b antagonists in pharmaceutical compositions
FI954964A (fi) vWF-pitoisten konsentraattien käyttö yhdistelmäterapiana antitromboottisilla ja fibrinolyyttisillä lääkeaineilla suoritettavassa terapiassa
BG104914A (en) Paroxetine maleate
ES2103220B1 (es) Desodorantes de los efluentes de papelera a base de ester de acido undecilenico.
MY111755A (en) Use of 4'-iodo-4'- deoxydoxorubicin for the treatment of amyloidosis.
IT1251497B (it) Uso di 1,2 dipalmitoil-l-alfa-fosfatidil-n,n-dimetiletanolammina, in composizioni dermatologiche
FI972637A0 (fi) K-ryhmän vitamiinin käyttö lisäkilpirauhasen liikatoiminnan hoitoon
BA95039A (bs) Set za prevenciju i terapiju bolne menstruacije
ITTO950286A0 (it) Uso dell'incenso in campo agronomico.
IT237103Y1 (it) Maschera per il viso per l'applicazione transdermica di sostanzein genere in particolare composizioni cosmetiche per il trattamento
GEP20002141B (en) Use of 2-Phenyl-1, 2-Benzisoselenazol-3(2H)-One for Prevention and/or Treatment of Dementia, a Pharmaceutical Composition for Prevention and/or Treatment of the Alzheimer’s Disease